| Akari Therapeutics Plc (AKTX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | ||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | ||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (3,041,000$) | (2,121,000$) | (3,256,000$) | (2,150,000$) | (2,124,000$) | (1,490,000$) | (4,894,000$) | (4,044,000$) | (4,409,000$) | (2,449,000$) | (4,694,000$) | (4,880,000$) | (7,440,576$) | (6,770,475$) | 5,302,892$ | (1,298,000$) | (1,988,478$) | (667,978$) | 3,567,154$ | (2,328,000$) | |||||||||||||||||||||||||||||
| Investing Cash Flow | (42,083$) | (18,779$) | 1,410,577$ | 0$ | 0$ | 0$ | 142,000$ | (142,000$) | |||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 42,083$ | 0$ | |||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 5,760,000$ | 1,897,000$ | 3,381,000$ | 2,133,000$ | 2,154,000$ | (443,000$) | 7,763,000$ | 1,514,000$ | 3,517,000$ | 0$ | 291,000$ | 3,212,000$ | (3,059,930$) | 72,104,349$ | 0$ | 0$ | 3,893,191$ | (7,876,815$) | 0$ | ||||||||||||||||||||||||||||||
| End Cash Position | 5,263,000$ | 2,544,000$ | 2,711,000$ | 2,582,000$ | 2,599,000$ | 2,246,000$ | 4,177,000$ | 1,310,000$ | 3,845,000$ | 4,731,000$ | 7,181,000$ | 11,582,000$ | 13,250,000$ | 9,361,000$ | 61,429,511$ | 68,919,995$ | 78,772,888$ | 2,718,000$ | 1,328,662$ | 3,327,468$ | 52,614$ | 11,358,000$ | |||||||||||||||||||||||||||
| Exchange Rate Effect | 0$ | (3,000$) | 1,000$ | 2,000$ | (2,000$) | (5,000$) | 6,000$ | (1,000$) | |||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (3,041,000$) | (2,121,000$) | (3,256,000$) | (2,150,000$) | (2,124,000$) | (1,490,000$) | (4,894,000$) | (4,044,000$) | (4,409,000$) | (2,449,000$) | (4,694,000$) | (4,880,000$) | (7,482,659$) | (6,770,475$) | 5,302,892$ | (1,298,000$) | (1,988,478$) | (667,978$) | 3,567,154$ | (2,328,000$) | |||||||||||||||||||||||||||||